Coronavirus Research International Society (COVRISO) is a non-profit organization, a global network of researchers and stakeholders sharing the common goal to conquer coronaviruses.
Our goal is to help the lives of million patients suffering from Covid-19 by facilitating an international network of research partnership and collaboration. The interdisciplinary nature of our research collaboration sparks creative solutions to problems caused by the Covid-19 pandemic.
The Society facilitates the collaboration between academia and industry, serves as a crowdsourcing hub of best research talents and sponsors for early career scientists from around the world.
We encourage a spirit of creative thinking, and open-minded researchers with scientific validation and new hypotheses to solve challenges in current medicine.
We help advance translational medicine by accelerating research collaboration worldwide to prevent and conquer the next coronavirus pandemic.
Coronavirus Research International Society is pleased to present the International Congress on Coronaviruses (ICCovid) which will be held on May 18-20, 2022 in San Francisco.
IC-Covid is an international gathering of researchers, scientists, business executives and stakeholders focusing on basic and applied research and the development of new drug therapeutics and vaccines for the prevention and treatment of Covid-19 and related infectious diseases.
The conference also provides a premier interdisciplinary platform for researchers, practitioners and educators to present the most recent innovations, trends, challenges solutions adopted in the fields of Virology and Immunology.
Learn more
Coronavirus Research International Society™ is a professional international society for individuals interested in scientific research focusing on coronaviruses. Be a part of a global network of researchers, scientists, and healthcare providers belong to various Professional Focused Areas (PFAs)
Learn more
Coronavirus Research International Society™ helps fund and accelerate the research and clinical trials of promising new drugs for the prevention and treatment of Covid-19 diseases. The funding is peer reviewed by a network of researchers on our Medical and Scientific Advisory Council.
Learn more
The Society offers a free, easy-to-use clinical studies matching service that generates customized lists of studies based on the patient's conditions. Working with our partners and government agencies, we have updated clinical trials database in the US and many countries around the world.
Learn more
The Society facilitates collaboration between international scientists and US based research organizations under US government funds. To apply for research collaboration and funding, please complete Funding Application Form.
Learn more
ICCovid 2022 is a leading forum in research and drug development for the prevention and treatment of Covid-19. The Congress will highlight the latest accomplishments in in vaccines and drug therapeutics and best practice in patient care for Covid-19.
Learn more
The deadline for abstract submission to the IC-Covid 2022 is September 30, 2021.
The deadline for late breaking news of clinical trial reports to the Congress October 31, 2021 Learn more
The International Congress on Coronaviruses ™ 2022 will be held on May 18-20, 2022
The preliminary conference schedule has been posted online:
Learn moreEarly bird registration will end on December 15, 2021
Regular registration will end on May 14, 2022.
On site registration rates will be applied from May 15-20, 2022.
Learn more